• This topic is empty.
Viewing 1 post (of 1 total)
  • Author
  • #12567

    The company is actively enrolling patients in the trial, evaluating rNAPc2 as a potential treatment for COVID-19 patients who are at high risk for thrombotic complications.

    More Information

Viewing 1 post (of 1 total)
  • You must be logged in to reply to this topic.